(Press-News.org) A research team at The Hastings Center has been approved for $1.5 million in funding by the Patient-Centered Outcomes Research Institute (PCORI) to study organizational trustworthiness as it relates to community-engaged research. Led by Virginia A. Brown, PhD, a research scholar at The Hastings Center, the study will be the first to investigate the role of organizational trustworthiness in shaping research engagement processes and outcomes.
Measures to assess organizational trustworthiness as it relates to research are lacking. This study will develop a measure and conduct a preliminary test of it. The study aims to:
Understand the perspectives of diverse patients and other partners (e.g., clinicians, researchers, community-based organizations) regarding organizational trustworthiness as it relates to research and how these perspectives have shaped interpersonal trust to improve engagement in research.
Develop and assess a new measure of organizational trustworthiness.
Examine the observable properties of organizational trustworthiness that the new measure identifies. To do this, the researchers will recruit 1,035 patients and others from past or currently funded PCORI engagement and research projects, PCORnet, and other community-engaged research projects to complete an online survey based on findings from the above two aims.
Dr. Brown’s study was selected through a PCORI Funding Announcement focused on building an evidence base to support development of measures and approaches that strengthen meaningful engagement in comparative clinical effectiveness research. Much has been learned in recent years about participatory research that seeks to involve the ultimate end users of study results, including patients, caregivers, clinicians, and others, as partners in the research process. But there has been little systematic study about which engagement techniques are most effective.
“This study was selected for PCORI funding for its potential to strengthen patient-centered and stakeholder-driven comparative clinical effectiveness research by providing evidence about specific engagement methods and measures that promote representative engagement of patients and other stakeholders in research,” said PCORI Executive Director Nakela L. Cook, MD, MPH. “We look forward to following the study’s progress and working with The Hastings Center to share the results.”
The Hastings Center’s award has been approved pending completion of a business and programmatic review by PCORI staff and issuance of a formal award contract.
PCORI is an independent, nonprofit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers, and clinicians with the evidence-based information needed to make better-informed health care decisions.
The Hastings Center is a nonprofit, nonpartisan bioethics research institute.
Research Team:
Lead PI:
Virginia A. Brown, PhD, research scholar, The Hastings Center
Co-PI:
Phillip W. Schnarrs, PhD, incoming professor in the Department of Behavioral and Community Health Sciences and co-director of the Center for LGBT Health at the University of Pittsburgh School of Public Health
Co-Investigators:
Nancy Berlinger, PhD, senior research scholar, The Hastings Center
Michael K Gusmano, PhD, professor of health policy, College of Health, Lehigh University
John Oeffinger, director of eLearning and Training, Texas Health Institute
AI Richmond, MSW, executive director, Community-Campus Partnerships for Health
Lauren Taylor, PhD, assistant professor, Department of Population Health, NYU Grossman School of Medicine
Andrew Yockey, PhD, assistant professor of public health, The University of Mississippi
Consultant
John Hughes, PhD, associate professor, Department of Community and Population Health, Lehigh University
To interview Virginia A. Brown, contact:
Susan Gilbert
Communications Director
The Hastings Center
gilberts@thehastingscenter.org
845.424.4040 x244
END
The Hastings Center awarded $1.5 million by PCORI to study organizational trustworthiness and community-engaged research
2024-08-13
ELSE PRESS RELEASES FROM THIS DATE:
Dairy nutrition is leading the sustainability charge
2024-08-13
Philadelphia, August 13, 2024 – Research into reducing greenhouse gas emissions from livestock has increased exponentially as the dairy and agriculture sectors work together toward shared sustainability and efficiency goals. While this progress has been made in all areas of dairy science research, from genetics to animal health and welfare, dairy nutrition has emerged as a particularly impactful area for emission reduction. In a new invited review in the Journal of Dairy Science, a preeminent voice in sustainability and dairy nutrition synthesizes ...
A new method for protection from plant pathogens could help support global food security.
2024-08-13
By modifying a plant intracellular immune receptor (NLR), researchers have developed a potential new strategy for resistance to rice blast disease, one of the most important diseases threatening global food security. The collaborative team from the UK and Japan have recently published their research in PNAS. This could have implications for future approaches to crop protection and ultimately global food supply stability.
The research was led from the Department of Biochemistry and Metabolism at the John Innes Centre, with partners at The Sainsbury Laboratory, University of East Anglia, and the Division of Genomics and Breeding, Iwate Biotechnology Research Center, Japan. For a ...
Halogen bonding for selective electrochemical separation, path to sustainable chemical processing demonstrated
2024-08-13
With a new polymer that only attracts certain substances from solutions when electrically activated, researchers have taken a major step towards sustainable chemical separation.
A team based at the University of Illinois Urbana-Champaign has reported the first demonstration of selective electrochemical separation driven by halogen bonding in the journal JACS Au. This was achieved by engineering a polymer that modulates the charge density on a halogen atom when electricity is applied. The polymer then attracts only certain targets – such as halides, oxyanions, and even organic molecules – from organic solutions, ...
Study reveals urban trees suffer more from heat waves and drought than their rural counterparts
2024-08-13
NEW YORK, August 13, 2024 — A recently published study in Ecological Applications details how trees in New York City and Boston are more negatively impacted by heat waves and drought than trees of the same species in nearby rural forests. The finding, made by researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC), highlights the challenges urban trees face in the context of climate change and underscores the importance of tailored urban forestry management as ...
New $7.7 million grant to propel search for medications for brain disorders
2024-08-13
JUPITER, Fla. — Children born with a damaged gene needed for healthy brain development, SYNGAP1, experience seizures, sensory processing disorders, difficulty speaking, intellectual disability, and autism-like behaviors. It’s a condition without any treatments, one that’s hard both on parents and children, said Gavin Rumbaugh, Ph.D., a neuroscientist at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology.
Rumbaugh and a team of scientists from the institute have been awarded a five-year grant from the National Institute of Mental Health worth $7.7 million to work toward a treatment. Their goal is to ...
National Cancer Institute awards grant to Hollings researchers focused on depression among cancer survivors
2024-08-13
Depression is common among people with likely incurable cancer – understandably so. But studies have shown that it can be treated, and if the goal is for individuals to be able to engage as much as possible with family, friends, hobbies or whatever gives them joy and purpose in whatever amount of time they have, then treating depression becomes imperative.
That’s not so easy, though, as patients may face a shortage of mental health workers, difficulties with transportation and continuing stigma around mental health issues.
Evan Graboyes, M.D., a head and neck surgical oncologist and director of Survivorship ...
MSK Research Highlights, August 13, 2024
2024-08-13
New research from Memorial Sloan Kettering Cancer Center (MSK) found patients with non-small cell lung cancer brain metastases may benefit from up-front stereotactic radiosurgery; identified a connection between antibiotic use and autoimmune diseases; and uncovered a previously unknown structural role for messenger RNAs in the cytoplasm of cells.
Patients with non-small cell lung cancer brain metastases may benefit from upfront stereotactic radiosurgery
For patients with non-small cell lung cancer that has spread to the brain, targeted therapies called ...
Study finds that dopaminergic medication improves sleep quality in Parkinson’s disease patients
2024-08-13
A study involving 22 Parkinson’s disease (PD) patients has shown that use of the dopaminergic drug levodopa improves sleep quality. When the patients took the drug, the number of times they woke up during the night fell 25% and the amount of time they remained awake fell 30% on average.
The investigation was conducted with FAPESP’s support by researchers at São Paulo State University (UNESP) in Brazil, and the University of Grenoble Alpes (UGA) in France. An article reporting the results is published in ...
Breakthrough in nanotechnology: Viewing the invisible with advanced microscopy
2024-08-13
Tailoring light with Nanomaterials
Metamaterials, engineered at the nanoscale, exhibit unique properties not found in naturally occurring materials. These properties arise from their nanoscale building blocks, which, until now, have been challenging to observe directly due to their size being smaller than the wavelength of light. The team's research overcomes this limitation by employing a new microscopy technique that can simultaneously reveal both the nano and macro structures of these materials.
A New Window into the Nano World
The key finding of this research is a methodological breakthrough that enables the visualization of structures previously too small to be seen ...
Tackling cancer from the inside out: A deep dive into immune checkpoint inhibitors
2024-08-13
In the past two decades, immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, showing promising results against various solid tumors. This study reviews recent developments in ICIs, focusing on new targets like T cell immunoreceptor with Ig and ITIM domains (TIGIT), T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3), and lymphocyte activation gene-3 (LAG-3). These targets aim to overcome resistance mechanisms limiting the effectiveness of current therapies, such as anti-PD-1 and anti-CTLA-4. By identifying and developing these new ...